1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EVOKE PHARMA INC
Evoke Pharma Inc XNAS: EVOK

Watchlist

Portfolio

Alert


Insider Trading disclosures for Evoke Pharma Inc

The latest disclosure was made by Cam L. Garner in Evoke Pharma Inc where a trade of 1,291 Stock Option (Right to Buy) done was reported to US exchanges on May 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,291 11,520 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,187 8,238 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,218 8,269 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,187 8,207 - - Stock Option (Right to Buy)
Benjamin Smeal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,125 6,958 - - Stock Option (Right to Buy)
Vickie W. Reed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 1,250 8,333 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 2.80 per share. 21 Mar 2025 1,000 9,820 (0%) 0% 2.8 2,797 Common Stock
Mark A. Kowieski Chief Financial Officer Grant, award, or other acquisition of securities at price $ 3.21 per share. 20 Mar 2025 4,500 4,916 (0%) 0% 3.2 14,463 Common Stock
Matthew J. D'Onofrio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 3.65 per share. 28 Feb 2025 6,849 8,820 (0%) 0% 3.7 24,999 Common Stock
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 8,750 8,750 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 5,833 5,833 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 70,000 70,000 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 5,833 5,833 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 5,833 5,833 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 11,000 11,000 - - Stock Option (Right to Buy)
Vickie W. Reed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 5,833 5,833 - - Stock Option (Right to Buy)
Mark A. Kowieski Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 13,000 13,000 - - Stock Option (Right to Buy)
Benjamin Smeal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Oct 2024 5,833 5,833 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2024 64,840 64,840 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2024 17,291 17,291 - - Stock Option (Right to Buy)
Mark A. Kowieski Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2024 17,291 17,291 - - Stock Option (Right to Buy)
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 17,750 17,750 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 14,625 14,625 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 14,625 14,625 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 14,250 14,250 - - Stock Option (Right to Buy)
Vickie W. Reed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 15,000 15,000 - - Stock Option (Right to Buy)
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 17,750 17,750 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 14,625 14,625 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 14,625 14,625 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 14,250 14,250 - - Stock Option (Right to Buy)
Vickie W. Reed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 15,000 15,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 30,000 30,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio President & Chief Op. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 25,000 25,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 15,000 15,000 - - Stock Option (Right to Buy)
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 67,500 67,500 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 57,750 57,750 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 57,750 57,750 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 56,000 56,000 - - Stock Option (Right to Buy)
Vickie S. Reed Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2022 58,000 58,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 175,000 175,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 100,000 100,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2022 100,000 100,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2021 415,000 415,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2021 300,000 300,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2021 300,000 300,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.94 per share. 11 Dec 2020 23,954 339,782 (1%) 0% 2.9 70,425 Common Stock
David A. Gonyer Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.90 per share. 11 Dec 2020 48,046 363,736 (1%) 0% 2.9 139,333 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale of securities on an exchange or to another person at price $ 2.95 per share. 10 Dec 2020 5,643 324,354 (1%) 0% 3.0 16,647 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale of securities on an exchange or to another person at price $ 2.91 per share. 10 Dec 2020 40,357 283,997 (1%) 0% 2.9 117,439 Common Stock
David A. Gonyer Director, President and CEO Other type of transaction at price $ 1.05 per share. 01 Sep 2020 20,238 339,782 (1%) 0% 1.1 21,250 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 1.05 per share. 01 Sep 2020 20,238 283,997 (1%) 0% 1.1 21,250 Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 1.05 per share. 01 Sep 2020 20,238 51,876 (0%) 0% 1.1 21,250 Common Stock
Cam L. Garner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 67,500 67,500 - - Stock Option (Right to Buy)
Ann D. Rhoads Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 61,750 61,750 - - Stock Option (Right to Buy)
Todd C. Brady Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 57,750 57,750 - - Stock Option (Right to Buy)
Malcolm R. Hill Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 54,000 54,000 - - Stock Option (Right to Buy)
Kenneth J. Widder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 May 2020 56,000 56,000 - - Stock Option (Right to Buy)
David A. Gonyer President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2020 325,000 325,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2020 200,000 200,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.85 per share. 28 Feb 2020 25,000 263,759 (1%) 0% 0.9 21,250 Common Stock
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2020 200,000 200,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 225,000 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 225,000 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 63,750 63,750 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 53,015 53,015 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 45,000 45,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 168,750 168,750 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 168,750 168,750 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 168,750 168,750 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 85,000 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 70,687 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 60,000 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 225,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 39,375 39,375 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 48,750 48,750 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 150,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 150,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 65,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 70,687 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 52,500 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 150,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 112,500 112,500 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 112,500 112,500 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 112,500 112,500 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 53,015 53,015 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 56,250 56,250 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 50,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 75,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 33,750 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 100,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 125,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2019 125,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 37,500 37,500 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 25,312 25,312 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 75,000 75,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 93,750 93,750 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2019 93,750 93,750 - - Stock Option (Right to Buy)
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2019 37,500 37,500 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2019 36,500 36,500 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2019 34,000 34,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2019 32,500 32,500 - - Stock Option (Right to Buy)
Kenneth J. Widder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2019 34,000 34,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 225,000 225,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 150,000 150,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2019 125,000 125,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Other type of transaction at price $ 1.63 per share. 31 Aug 2018 6,901 319,544 (1%) 0% 1.6 11,249 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 1.63 per share. 31 Aug 2018 13,036 238,759 (1%) 0% 1.6 21,249 Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 1.63 per share. 31 Aug 2018 3,101 31,638 (0%) 0% 1.6 5,055 Common Stock
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 37,500 37,500 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 32,500 32,500 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 36,500 36,500 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 34,000 34,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 225,000 225,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 150,000 150,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 31,500 31,500 - - Stock Option (Right to Buy)
Kenneth J. Widder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 34,000 34,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2018 125,000 125,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Other type of transaction at price $ 2.15 per share. 31 Aug 2017 8,240 312,643 (2%) 0% 2.2 17,716 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 2.15 per share. 31 Aug 2017 1,115 225,723 (1%) 0% 2.1 2,397 Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 2.15 per share. 31 Aug 2017 4,023 28,537 (0%) 0% 2.1 8,649 Common Stock
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 37,500 37,500 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 32,500 32,500 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 36,500 36,500 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 34,000 34,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 31,500 31,500 - - Stock Option (Right to Buy)
Kenneth J. Widder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 34,000 34,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Other type of transaction at price $ 1.60 per share. 28 Feb 2017 12,000 304,403 (2%) 0% 1.6 19,200 Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 1.60 per share. 28 Feb 2017 12,000 224,608 (1%) 0% 1.6 19,200 Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 1.60 per share. 28 Feb 2017 7,875 24,514 (0%) 0% 1.6 12,600 Common Stock
Kenneth J. Widder None Purchase of securities on an exchange or from another person at price $ 2.90 per share. 22 Feb 2017 418,605 1,472,867 (9%) 2% 2.9 1,213,955 Common Stock
Kenneth J. Widder None Purchase of securities on an exchange or from another person at price $ 2.90 per share. 22 Feb 2017 20,930 73,641 (0%) 0% 2.9 60,697 Common Stock
Kenneth J. Widder None Purchase of securities on an exchange or from another person at price $ 2.90 per share. 22 Feb 2017 10,465 36,821 (0%) 0% 2.9 30,349 Common Stock
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 225,000 225,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 150,000 150,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 100,000 100,000 - - Stock Option (Right to Buy)
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 20,500 20,500 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 21,500 21,500 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 17,500 17,500 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 19,000 19,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 16,500 16,500 - - Stock Option (Right to Buy)
Kenneth J. Widder Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 19,000 19,000 - - Stock Option (Right to Buy)
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Apr 2016 61 16,208 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Apr 2016 21 16,269 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Apr 2016 3,603 950,403 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Apr 2016 1,492 954,006 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 632 16,366 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 76 16,290 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 37,054 959,922 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Apr 2016 4,424 955,498 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Apr 2016 4,348 996,976 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Apr 2016 75 16,998 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 251 17,073 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 8,669 1,043,659 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 475 17,324 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 14,554 1,001,324 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 148 17,799 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Apr 2016 27,781 1,015,878 - - Common Stock
David A. Gonyer Director, President and CEO Other type of transaction at price $ 0.00 per share. 01 Mar 2016 4,669 292,403 - - Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 0.00 per share. 01 Mar 2016 10,937 212,608 - - Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 0.00 per share. 01 Mar 2016 7,331 16,639 - - Common Stock
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 60,000 60,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 94,250 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 70,687 70,687 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 80,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 70,000 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 70,687 70,687 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 94,250 0 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 52,500 52,500 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 33,750 33,750 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 100,000 0 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2016 75,000 75,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Feb 2016 45,000 0 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2016 85,000 85,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2016 65,000 65,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2016 50,000 50,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Other type of transaction at price $ 0.00 per share. 31 Aug 2015 4,023 287,734 - - Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 0.00 per share. 31 Aug 2015 1,994 9,308 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Aug 2015 202 17,947 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Aug 2015 11,836 1,052,328 - - Common Stock
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Kenneth J. Widder Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Apr 2015 9,000 9,000 - - Stock Option (Right to Buy)
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 554 18,149 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 9,832 1,104,495 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 135 18,703 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 7,920 1,096,575 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 168 18,838 - - Common Stock
Jesse I. Treu Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Apr 2015 32,411 1,064,164 - - Common Stock
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2015 80,000 80,000 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2015 70,000 70,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Other type of transaction at price $ 0.00 per share. 27 Feb 2015 2,711 283,711 - - Common Stock
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Other type of transaction at price $ 0.00 per share. 27 Feb 2015 6,671 201,671 - - Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 0.00 per share. 27 Feb 2015 6,058 7,314 - - Common Stock
David A. Gonyer Director, President and CEO 31 Dec 2014 164,000 281,000 - - Common Stock
David A. Gonyer Director, President and CEO 31 Dec 2014 164,000 281,000 - - Common Stock
Todd C. Brady None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Sep 2014 4,000 4,000 - - Common Stock
Malcolm R. Hill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 5,250 0 - - Stock Option (right to buy)
Malcolm R. Hill None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2014 5,250 19,250 - - Common Stock
Marilyn R. Carlson Chief Medical Officer Other type of transaction at price $ 0.00 per share. 29 Aug 2014 1,256 1,256 - - Common Stock
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Kenneth J. Widder Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2014 9,000 9,000 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2014 45,000 45,000 - - Stock Option (Right to Buy)
David A. Gonyer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2013 94,250 94,250 - - Stock Option (Right to Buy)
Matthew J. D'Onofrio Exec VP, Chief Bus. Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2013 94,250 94,250 - - Stock Option (Right to Buy)
Marilyn R. Carlson Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2013 100,000 100,000 - - Stock Option (Right to Buy)
James C. Blair Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
James C. Blair Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
James C. Blair Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
James C. Blair Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Jesse I. Treu Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
Jesse I. Treu Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
Jesse I. Treu Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Jesse I. Treu Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
Cam L. Garner None 30 Sep 2013 78,027 0 - - Series A Preferred Stock
Cam L. Garner None 30 Sep 2013 15,605 335,605 - - Common Stock
Brian H. Dovey Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
Brian H. Dovey Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
Brian H. Dovey Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Brian H. Dovey Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
Nicole Vitullo Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
Nicole Vitullo Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
Nicole Vitullo Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
Nicole Vitullo Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Scott L. Glenn None 30 Sep 2013 78,027 0 - - Series A Preferred Stock
Scott L. Glenn None 30 Sep 2013 15,605 15,605 - - Common Stock
Brian K. Halak Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
Brian K. Halak Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Brian K. Halak Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
Brian K. Halak Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
Schoemaker K Kathleen Ten Percent Owner 30 Sep 2013 1,114,327 1,114,327 - - Common Stock
Schoemaker K Kathleen Ten Percent Owner 30 Sep 2013 19,006 0 - - Series A Preferred Stock
Schoemaker K Kathleen Ten Percent Owner 30 Sep 2013 19,006 19,006 - - Common Stock
Schoemaker K Kathleen Ten Percent Owner 30 Sep 2013 1,114,327 0 - - Series A Preferred Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 5,271,317 0 - - Series A Preferred Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 1,054,262 1,054,262 - - Common Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 263,556 0 - - Series A Preferred Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 131,784 0 - - Series A Preferred Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 52,711 52,711 - - Common Stock
Kenneth J. Widder Director, Ten Percent Owner 30 Sep 2013 26,356 26,356 - - Common Stock
Cam L. Garner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
Ann D. Rhoads None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
Scott L. Glenn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
Todd C. Brady None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
Malcolm R. Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
Kenneth J. Widder Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2013 18,000 18,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters